182 related articles for article (PubMed ID: 35251909)
1. Mechanistic insights from the review and evaluation of ayurvedic herbal medicines for the prevention and management of COVID-19 patients.
Sarkar PK; Das Mukhopadhyay C
J Herb Med; 2022 Mar; 32():100554. PubMed ID: 35251909
[TBL] [Abstract][Full Text] [Related]
2. Two pronged approach for prevention and therapy of COVID-19 (Sars-CoV-2) by a multi-targeted herbal drug, a component of ayurvedic decoction.
Shukla R; Singh S; Singh A; Misra K
Eur J Integr Med; 2021 Apr; 43():101268. PubMed ID: 33520014
[TBL] [Abstract][Full Text] [Related]
3. Antiviral Activity of Svarnvir-IV Tablet Assayed for Activity Against SARS-CoV-2 In Vitro.
Reddy KR; Sahni C; Sharma S
Cureus; 2023 May; 15(5):e39421. PubMed ID: 37362483
[TBL] [Abstract][Full Text] [Related]
4. Ayurvedic treatment of COVID-19: A case report.
Girija PLT; Sivan N
J Ayurveda Integr Med; 2022; 13(1):100329. PubMed ID: 32680602
[TBL] [Abstract][Full Text] [Related]
5. Ayurvedic formulations: Potential COVID-19 therapeutics?
Mahaboob Ali AA; Bugarcic A; Naumovski N; Ghildyal R
Phytomed Plus; 2022 Aug; 2(3):100286. PubMed ID: 35474908
[TBL] [Abstract][Full Text] [Related]
6. Modulation of neutrophil (dys)function by Ayurvedic herbs and its potential influence on SARS-CoV-2 infection.
Joshi MB; Kamath A; Nair AS; Yedehali Thimmappa P; Sriranjini SJ; Gangadharan GG; Satyamoorthy K
J Ayurveda Integr Med; 2022; 13(1):100424. PubMed ID: 33746457
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of traditional ayurvedic Kadha for prevention and management of the novel Coronavirus (SARS-CoV-2) using in silico approach.
Maurya DK; Sharma D
J Biomol Struct Dyn; 2022 Jun; 40(9):3949-3964. PubMed ID: 33251972
[TBL] [Abstract][Full Text] [Related]
8. Characterization of SARS-CoV-2-Specific Humoral and Cellular Immune Responses Induced by Inactivated COVID-19 Vaccines in a Real-World Setting.
Li Z; Xiang T; Liang B; Deng H; Wang H; Feng X; Quan X; Wang X; Li S; Lu S; Yang X; Wang B; Zelinskyy G; Trilling M; Sutter K; Lu M; Dittmer U; Yang D; Zheng X; Liu J
Front Immunol; 2021; 12():802858. PubMed ID: 35003131
[TBL] [Abstract][Full Text] [Related]
9. Repurposing potential of Ayurvedic medicinal plants derived active principles against SARS-CoV-2 associated target proteins revealed by molecular docking, molecular dynamics and MM-PBSA studies.
Kumar Verma A; Kumar V; Singh S; Goswami BC; Camps I; Sekar A; Yoon S; Lee KW
Biomed Pharmacother; 2021 May; 137():111356. PubMed ID: 33561649
[TBL] [Abstract][Full Text] [Related]
10. An ayurvedic perspective along with in silico study of the drugs for the management of SARS-CoV-2.
Gandhi AJ; Rupareliya JD; Shukla VJ; Donga SB; Acharya R
J Ayurveda Integr Med; 2022; 13(1):100343. PubMed ID: 32837100
[TBL] [Abstract][Full Text] [Related]
11. Immuno-Informatics Quest against COVID-19/SARS-COV-2: Determining Putative T-Cell Epitopes for Vaccine Prediction.
Akhtar N; Joshi A; Singh B; Kaushik V
Infect Disord Drug Targets; 2021; 21(4):541-552. PubMed ID: 32957905
[TBL] [Abstract][Full Text] [Related]
12. A Bacteriophage-Based, Highly Efficacious, Needle- and Adjuvant-Free, Mucosal COVID-19 Vaccine.
Zhu J; Jain S; Sha J; Batra H; Ananthaswamy N; Kilgore PB; Hendrix EK; Hosakote YM; Wu X; Olano JP; Kayode A; Galindo CL; Banga S; Drelich A; Tat V; Tseng CK; Chopra AK; Rao VB
mBio; 2022 Aug; 13(4):e0182222. PubMed ID: 35900097
[TBL] [Abstract][Full Text] [Related]
13. Scientific basis for the use of Indian ayurvedic medicinal plants in the treatment of neurodegenerative disorders: ashwagandha.
Ven Murthy MR; Ranjekar PK; Ramassamy C; Deshpande M
Cent Nerv Syst Agents Med Chem; 2010 Sep; 10(3):238-46. PubMed ID: 20528765
[TBL] [Abstract][Full Text] [Related]
14. Phytotherapic Drugs for COVID-19 Treatment: A Scoping Review.
Singh M; Trivedi D; Mohapatra R; Bagchi T; Durthi CP; Kuppam C
Curr Pharm Des; 2021 Oct; 27(31):3389-3398. PubMed ID: 34225610
[TBL] [Abstract][Full Text] [Related]
15. Immunogenicity, durability, and safety of an mRNA and three platform-based COVID-19 vaccines as a third dose following two doses of CoronaVac in China: A randomised, double-blinded, placebo-controlled, phase 2 trial.
Zhang Y; Ma X; Yan G; Wu Y; Chen Y; Zhou Z; Wan N; Su W; Liu FW; Dai MX; Yang M; Li C; Yu X; Zhang L; Wang Z; Zhou TC; You D; Wei J; Zhang Z;
EClinicalMedicine; 2022 Dec; 54():101680. PubMed ID: 36188435
[TBL] [Abstract][Full Text] [Related]
16. Traditional Herbal Medicines, Bioactive Metabolites, and Plant Products Against COVID-19: Update on Clinical Trials and Mechanism of Actions.
Alam S; Sarker MMR; Afrin S; Richi FT; Zhao C; Zhou JR; Mohamed IN
Front Pharmacol; 2021; 12():671498. PubMed ID: 34122096
[TBL] [Abstract][Full Text] [Related]
17. Adjuvant effect of Japanese herbal medicines on the mucosal type 1 immune responses to human papillomavirus (HPV) E7 in mice immunized orally with Lactobacillus-based therapeutic HPV vaccine in a synergistic manner.
Taguchi A; Kawana K; Yokoyama T; Adachi K; Yamashita A; Tomio K; Kojima S; Oda K; Fujii T; Kozuma S
Vaccine; 2012 Aug; 30(36):5368-72. PubMed ID: 22727726
[TBL] [Abstract][Full Text] [Related]
18. Structure-based lead optimization of herbal medicine rutin for inhibiting SARS-CoV-2's main protease.
Huynh T; Wang H; Luan B
Phys Chem Chem Phys; 2020 Nov; 22(43):25335-25343. PubMed ID: 33140777
[TBL] [Abstract][Full Text] [Related]
19. Antiviral Essential Oils Incorporated in Nanocarriers: Strategy for Prevention from COVID-19 and Future Infectious Pandemics.
Kaur M; Devi G; Nagpal M; Singh M; Dhingra GA; Aggarwal G
Pharm Nanotechnol; 2020; 8(6):437-451. PubMed ID: 33069206
[TBL] [Abstract][Full Text] [Related]
20. Recombinant COVID-19 vaccine based on recombinant RBD/Nucleoprotein and saponin adjuvant induces long-lasting neutralizing antibodies and cellular immunity.
Ghaemi A; Roshani Asl P; Zargaran H; Ahmadi D; Hashimi AA; Abdolalipour E; Bathaeian S; Miri SM
Front Immunol; 2022; 13():974364. PubMed ID: 36159845
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
